Cosmo Electronics Corporation (TPE:2466)

Verve Therapeutics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,703	12,002	6,524	5,589	5,910	5,112
Market Cap Growth	108.64%	83.97%	16.73%	-5.43%	15.60%	-4.25%
Enterprise Value	15,372	13,576	7,772	6,925	7,337	6,379
Last Close Price	79.00	70.00	38.05	32.43	34.32	29.78
PE Ratio	-	-	216.87	50.40	107.57	802.79
PS Ratio	11.60	10.84	6.19	4.02	4.40	4.11
PB Ratio	7.21	6.08	3.47	2.94	3.55	3.12
P/TBV Ratio	7.25	6.12	3.49	2.96	3.58	3.15
P/FCF Ratio	-	-	62.15	-	-	20.24
P/OCF Ratio	150.63	432.29	40.44	76.72	104.16	19.05
EV/Sales Ratio	13.01	12.26	7.38	4.98	5.47	5.12
EV/EBITDA Ratio	-	-	-	52.99	84.49	449.14
EV/EBIT Ratio	-	-	-	177.12	10119.51	-
EV/FCF Ratio	-137.27	-	74.04	-	-	25.25
Debt / Equity Ratio	0.95	0.89	1.10	1.05	1.13	1.21
Debt / EBITDA Ratio	-	-	-	13.34	19.18	72.79
Debt / FCF Ratio	-	-	19.73	-	-	7.85
Asset Turnover	0.27	0.26	0.24	0.33	0.33	0.30
Inventory Turnover	1.77	1.84	1.53	1.95	2.47	2.26
Quick Ratio	0.22	0.22	0.83	0.95	0.57	1.57
Current Ratio	0.59	0.58	1.46	1.70	0.90	2.14
Return on Equity (ROE)	-2.35%	-1.50%	1.59%	6.22%	3.32%	0.38%
Return on Assets (ROA)	-2.00%	-2.06%	-1.62%	0.58%	0.01%	-1.31%
Return on Capital (ROIC)	-2.27%	-2.32%	-1.79%	0.66%	0.01%	-1.52%
Return on Capital Employed (ROCE)	-	-	-	1.20%	0.00%	-
Earnings Yield	-0.33%	-0.24%	0.46%	1.98%	0.93%	0.13%
FCF Yield	-0.82%	-1.24%	1.61%	-0.58%	-3.50%	4.94%
Dividend Yield	-	-	-	0.57%	-	-
Buyback Yield / Dilution	-0.00%	0.04%	4.25%	-4.74%	-0.05%	-0.06%
Total Shareholder Return	-	0.04%	4.25%	-4.17%	-0.05%	-0.06%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.